UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045029
Receipt number R000051426
Scientific Title Basic research on motor and cognitive learning using virtual reality
Date of disclosure of the study information 2021/09/01
Last modified on 2021/08/01 10:58:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of exercise in a virtual reality (VR) space on motor and cognitive learning

Acronym

Effects of exercise in a virtual reality (VR) space on motor and cognitive learning

Scientific Title

Basic research on motor and cognitive learning using virtual reality

Scientific Title:Acronym

Basic research on motor and cognitive learning using virtual reality

Region

Japan


Condition

Condition

Healthy adults between 20 and 80 years of age

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study was to investigate the process of motor learning in healthy adults using virtual reality (VR), real-life, and VR combined with transcranial direct current electrical stimulation (tDCS). By clarifying the learning process in VR and real life, and whether or not tDCS can affect learning, we can provide basic information for future application to actual cases of central nervous system diseases.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Box and Block Test (measurement of the number of blocks that can be carried in one minute) will be conducted before and after each intervention condition to examine the effectiveness.

Key secondary outcomes

Motor evoked potentials to evaluate the excitability of the corticospinal tract, cognitive tasks (Kohs block design test, Rey-Osterrieth Complex Figure Test, nasal finger-nose test, BIT (Behavioral Inattention Test) imitation task), and motor tasks (Simple Test for Evaluating Hand Function) will be conducted before and after each intervention condition.


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

6

Purpose of intervention

Treatment

Type of intervention

Device,equipment Maneuver

Interventions/Control_1

20 minutes of exercise task in the real world => 1 week of washout period => 20 minutes of exercise task in VR space => 1 week of washout period => 20 minutes of exercise task in VR space + tDCS.
The VR device is a Leap Motion Controller (80mm x 30mm x 11mm) manufactured by Leap Motion. When the user moves his/her fingers in front of the sensor camera, the fingers on the PC screen move in real time. The exercise task is performed in this VR space.
The tDCS device is the GD-800 Compact-DC Stimulator (75mm x 75mm x 44mm, 140g) manufactured by OG Giken. An electrode pad (5cm x 7cm) is placed on the head non-invasively, and a weak current with a stimulus intensity of 1 or 2mA or less is applied for about 20 minutes.

Interventions/Control_2

20 minutes of exercise task in the real world => 1 week of washout period => 20 minutes of exercise task in VR space + tDCS => 1 week of washout period => 20 minutes of exercise task in VR space.

Interventions/Control_3

20 minutes exercise task in VR space => 1 week washout period => 20 minutes exercise task in real world => 1 week washout period => 20 minutes exercise task in VR space + tDCS.

Interventions/Control_4

20 minutes exercise task in VR space => 1 week washout period => 20 minutes exercise task in VR space + tDCS => 1 week washout period => 20 minutes exercise task in real world.

Interventions/Control_5

20 minutes of exercise task in VR space + tDCS => 1 week of washout period => 20 minutes of exercise task in VR space => 1 week of washout period => 20 minutes of exercise task in real world.

Interventions/Control_6

20 minutes of exercise task in VR space + tDCS => 1 week of washout period => 20 minutes of exercise task in real world => 1 week of washout period => 20 minutes of exercise task in VR space.

Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

Those who have received sufficient explanations about participation in this study and have obtained the written consent of the subject of their own free will with full understanding.

Key exclusion criteria

Subjects who fall under any one of the following are excluded.
(1) Subjects with a history of epilepsy
(2) Do not have a history of central nervous system disease or motor system disease that causes functional impairment of the upper limbs.
(3) Pregnant women, those who may be pregnant, or those who are breastfeeding.
(4) Those who have participated in other clinical trials within the past 4 months.
(5) Others who are judged by the principal investigator to be inappropriate as research subjects.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Hideaki
Middle name
Last name Matsuo

Organization

University of Fukui hospital

Division name

Division of Physical Therapy and Rehabilitation Medicine

Zip code

910-1193

Address

Matsuoka Shimoaizuki 23, Eiheiji, Fukui

TEL

0776613111

Email

hideakim@u-fukui.ac.jp


Public contact

Name of contact person

1st name Hideaki
Middle name
Last name Matsuo

Organization

University of Fukui hospital

Division name

Division of Physical Therapy and Rehabilitation Medicine

Zip code

910-1193

Address

Matsuoka Shimoaizuki 23, Eiheiji, Fukui

TEL

0776613111

Homepage URL


Email

hideakim@u-fukui.ac.jp


Sponsor or person

Institute

University of Fukui hospital

Institute

Department

Personal name



Funding Source

Organization

University of Fukui hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Research Ethics Committee of University of Fukui

Address

Matsuoka Shimoaizuki 23, Eiheiji, Fukui

Tel

0776613111

Email

chiken@ml.u-fukui.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2021 Year 09 Month 01 Day

Date of IRB


Anticipated trial start date

2021 Year 09 Month 01 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 08 Month 01 Day

Last modified on

2021 Year 08 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051426